Structure Therapeutics Inc.

Structure Therapeutics is a drugmaker working on oral medications to treat chronic diseases like obesity and pulmonary fibrosis. The company's main experimental drug, GSBR-1290, is designed to help with weight loss and is currently being tested in patient trials. Structure is still in the early stages of drug development and has not yet brought any products to market.